Abstract
Preliminary studies with the modified Field & Caspary (1970) system (the MOD MEM of Pritchard et al., 1972a) confirm sensitization of lymphocytes from thirteen cancer patients to encephalitogenic factor (EF) or cancer basic protein (Ca.BP). A control group of eleven subjects consisting of four normals and seven hospital patients without malignant disease showed no such sensitization.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Caspary E. A., Field E. J. Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? Br Med J. 1971 Jun 12;2(5762):613–617. doi: 10.1136/bmj.2.5762.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Field E. J., Caspary E. A. Lymphocyte sensitisation: an in-vitro test for cancer? Lancet. 1970 Dec 26;2(7687):1337–1341. doi: 10.1016/s0140-6736(70)92361-5. [DOI] [PubMed] [Google Scholar]
- Field E. J., Caspary E. A. M.E.M. test for malignant disease. Lancet. 1972 Oct 14;2(7781):826–827. doi: 10.1016/s0140-6736(72)92190-3. [DOI] [PubMed] [Google Scholar]
- Glucagon. Lancet. 1972 Sep 23;2(7778):637–638. [PubMed] [Google Scholar]
- Perper R. J., Zee T. W., Mickelson M. M. Purification of lymphocytes and platelets by gradient centrifugation. J Lab Clin Med. 1968 Nov;72(5):842–848. [PubMed] [Google Scholar]
- Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Immunodiagnosis of cancer. Br Med J. 1972 Sep 30;3(5830):823–823. doi: 10.1136/bmj.3.5830.823. [DOI] [PMC free article] [PubMed] [Google Scholar]